Cargando…

Molecular mimicry and cancer vaccine development

BACKGROUND: The development of cancer immunotherapeutic strategies relies on the identification and validation of optimal target tumor antigens, which should be tumor-specific as well as able to elicit a swift and potent anti-tumor immune response. The vast majority of such strategies are based on t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tagliamonte, Maria, Cavalluzzo, Beatrice, Mauriello, Angela, Ragone, Concetta, Buonaguro, Franco M., Tornesello, Maria Lina, Buonaguro, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131527/ https://www.ncbi.nlm.nih.gov/pubmed/37101139 http://dx.doi.org/10.1186/s12943-023-01776-0

Ejemplares similares

Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
por: Ragone, Concetta, et al.
Publicado: (2022)

Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case
por: Manolio, Carmen, et al.
Publicado: (2022)

Novel Molecular Targets for Hepatocellular Carcinoma
por: Cavalluzzo, Beatrice, et al.
Publicado: (2021)

Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides
por: Mauriello, Angela, et al.
Publicado: (2021)

Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy
por: Petrizzo, Annacarmen, et al.
Publicado: (2021)

Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs).
por: Ragone, Concetta, et al.
Publicado: (2021)

High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
por: Mauriello, Angela, et al.
Publicado: (2019)

Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2020)

Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2022)

Systems Biology Approach for Cancer Vaccine Development and Evaluation
por: Circelli, Luisa, et al.
Publicado: (2015)

Identification and characterization of heteroclitic peptides in TCR-binding positions with improved HLA-binding efficacy
por: Cavalluzzo, Beatrice, et al.
Publicado: (2021)

Immunological effects of adjuvants in subsets of antigen presenting cells of cancer patients undergoing chemotherapy
por: Mauriello, Angela, et al.
Publicado: (2020)

The impact of antigenic molecular mimicry on anti-cancer T-cell immune response
por: Tagliamonte, Maria, et al.
Publicado: (2022)

MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response
por: Tagliamonte, Maria, et al.
Publicado: (2021)

Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example
por: Buonaguro, Luigi, et al.
Publicado: (2007)

Conformational HIV-1 Envelope on particulate structures: a tool for chemokine coreceptor binding studies
por: Tagliamonte, Maria, et al.
Publicado: (2011)

Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach
por: Petrizzo, Annacarmen, et al.
Publicado: (2014)

SARS-CoV-2 RNA polymerase as target for antiviral therapy
por: Buonaguro, Luigi, et al.
Publicado: (2020)

Selecting Target Antigens for Cancer Vaccine Development
por: Buonaguro, Luigi, et al.
Publicado: (2020)

Systems biology applied to vaccine and immunotherapy development
por: Buonaguro, Luigi, et al.
Publicado: (2011)

Effects of adjuvants on IgG subclasses elicited by virus-like Particles
por: Visciano, Maria Luisa, et al.
Publicado: (2012)

HLA Does Not Impact on Short-Medium-Term Antibody Response to Preventive Anti-SARS-Cov-2 Vaccine
por: Ragone, Concetta, et al.
Publicado: (2021)

Cellular prognostic markers in hepatitis-related hepatocellular carcinoma
por: Petrizzo, A., et al.
Publicado: (2018)

The Molecular Interplay between Human Oncoviruses and Telomerase in Cancer Development
por: Tornesello, Maria Lina, et al.
Publicado: (2022)

The XIX century smallpox prevention in Naples and the risk of transmission of human blood-related pathogens
por: Buonaguro, Franco Maria, et al.
Publicado: (2015)

New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology
por: Tornesello, Anna Lucia, et al.
Publicado: (2017)

Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers
por: Tornesello, Maria Lina, et al.
Publicado: (2018)

Role of TP53 polymorphisms in sub-Saharan mucosal cancers
por: Buonaguro, Franco M, et al.
Publicado: (2010)

Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
por: Tornesello, Anna Lucia, et al.
Publicado: (2020)

The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2018)

Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections
por: Tornesello, Maria Lina, et al.
Publicado: (2016)

Viral and Cellular Biomarkers in the Diagnosis of Cervical Intraepithelial Neoplasia and Cancer
por: Tornesello, Maria Lina, et al.
Publicado: (2013)

Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients
por: Petrizzo, Annacarmen, et al.
Publicado: (2018)

Innate immunity and hepatitis C virus infection: a microarray’s view
por: Buonaguro, Luigi, et al.
Publicado: (2012)

Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2017)

Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting
por: Petrizzo, Annacarmen, et al.
Publicado: (2017)

Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents
por: Borrelli, Antonella, et al.
Publicado: (2018)

Peptide-based vaccine for cancer therapies
por: Buonaguro, Luigi, et al.
Publicado: (2023)

Corrigendum: Peptide-based vaccine for cancer therapies
por: Buonaguro, Luigi, et al.
Publicado: (2023)

The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer
por: Cerasuolo, Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vbk4sdus9e4osnkfhj7qk50cti